About Transcell Biosciences Private Limited
Data last updated: 06 February 2026
Transcell Biosciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in manufacturing, a part of the broader chemicals sector. Incorporated on 11 May 2022.
Registered with ROC Hyderabad under CIN U24290TG2022PTC162503.
Capital: an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.81 Cr. It is led by directors Uday Chatterjee and Subhadra Dravida.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Western Pearl 8Th Floor 8 – A Sy No 13(P) Hi – Tech City Main Road Kondapur, Hyderabad, Telangana, India – 500084.
The company is associated with 1 brand - Transcell Biosciences. As per MCA filings, the company has open charges of ₹1 Cr and satisfied charges of ₹1 Cr on record.
For more details, the company can be reached via its website transcell.in.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered AddressWestern Pearl 8Th Floor 8 – A Sy No 13(P) Hi – Tech City Main Road Kondapur, Hyderabad, Telangana, India – 500084
-
IndustryChemicals, Manufacturing, Other Chemical Product
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Transcell Biosciences Private Limited
Transcell Biosciences Private Limited operates one associated brand: Transcell Biosciences. These brands represent Transcell Biosciences Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Stem cell banking and biobanking services are provided by Transcell Biosciences. | transcell.in |
Competitors & Alternatives of Transcell Biosciences Private Limited
Brands and companies operating in the same space as Transcell Biosciences Private Limited include StemCyte, Forever Labs, China Cord Blood and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
StemCyte
|
Umbilical cord blood stem cell transplantation and therapeutic products company | Covina, United States, United States | 1997 |
Forever Labs
|
Stem cells are stored and preserved for future therapeutic applications. | Detroit, United States, United States | 2015 |
China Cord Blood
|
Biobanking services for umbilical cord blood stem cells are provided. | Hong Kong, China, China | 2003 |
LaCell
|
Stem Cell Production | New Orleans, United States, United States | 2010 |
Provia Labs
|
Stem cell biobanking and manufacturing from children's teeth are provided. | Littleton, United States, United States | 2009 |
Mill Creek Life Sciences
|
Tools and technologies to support the development and application of cellular and biologic therapeutics | Rochester, United States, United States | 2010 |
Generate
|
Provider of services for the storage of stem cells | Los Angeles, United States, United States | 1977 |
Board of Directors of Transcell Biosciences Private Limited
Transcell Biosciences Private Limited is governed by 2 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Uday Chatterjee | Director | 11 May 2022 | 4 Years 2 Months | Current |
| Subhadra Dravida | Director | 11 May 2022 | 4 Years 2 Months | Current |
Financials of Transcell Biosciences Private Limited FY 2025 filings available
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Transcell Biosciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Nov 2019 | Hdfc Bank Limited | ₹1 Cr | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Transcell Biosciences Private Limited
View historical data on people associated with Transcell Biosciences Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Transcell Biosciences Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Transcell Biosciences Private Limited
GSTIN & GST Filing Data of Transcell Biosciences Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Transcell Biosciences Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Transcell Biosciences Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Transcell Biosciences Private Limited
MSME Payment Delays by Transcell Biosciences Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Transcell Biosciences Private Limited
Subsidiaries & Group Companies of Transcell Biosciences Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Transcell Biosciences Private Limited with ownership details.
MCA Filings & Documents of Transcell Biosciences Private Limited
MCA Filings & Documents of Transcell Biosciences Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Transcell Biosciences Private Limited
Recent News on Transcell Biosciences Private Limited
Frequently Asked Questions about Transcell Biosciences Private Limited
Transcell Biosciences Private Limited is an active private limited company in the chemicals sector based in Hyderabad, Telangana, India. It was incorporated on 11 May 2022 (4+ years old) and is registered under CIN U24290TG2022PTC162503.
The current directors of Transcell Biosciences Private Limited are:
The primary industry of Transcell Biosciences Private Limited is chemicals. The company specifically operates in manufacturing. The company is currently active in this sector.
Transcell Biosciences Private Limited can be reached at the registered office: Western Pearl 8Th Floor 8 – A Sy No 13P Hi – Tech City Main Road Kondapur, Hyderabad, Telangana, India – 500084, or through the website transcell.in.
The authorised capital is ₹3 Cr, and the paid-up capital is ₹2.81 Cr.
The company has its registered office at Western Pearl 8Th Floor 8 – A Sy No 13P Hi – Tech City Main Road Kondapur, Hyderabad, Telangana, India – 500084.